Tradestie Institutional Equity Comparison Engine
TPST vs FEMY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FEMY Overall Edge
FEMY Captures Institutional Edge (2โ1 Pillars ยท 4โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Femasys Inc. Common Stock (FEMY) driven by superior Momentum & Technical, Options & Structure while TPST counters with relative strength in Growth & Margin. Fundamentally, TPST trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus FEMY at N/M Forward P/E and -763.9% operating margin (-18.9% YoY). In options structure, TPST sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against FEMY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
TPST N/M vs FEMY N/M Fwd P/E
Growth & Margin Winner
TPST
Op Margin 0.0% vs -763.9% ยท YoY +0.0% vs -18.9%
Momentum & Technical Winner
FEMY
1Y -96.1% vs +54.8% ยท 52W Pos 0% vs 17%
Options & Structure Winner
FEMY
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
TPST
NASDAQ
Tempest Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$0.34
-10.5% 1D
Market Cap
$7.6M
1M Return
-45.24%
1Y Return
-96.14%
Forward P/E
N/M
Unified AI Score
39.3 / 100
SELL
Tech 25.0
Fund 52.0
Flow 50.0
Mom 55.0
FEMY
NASDAQ
Femasys Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.28
-9.86% 1D
Market Cap
$11.9M
1M Return
-22.42%
1Y Return
+54.78%
Forward P/E
N/M
Unified AI Score
52.6 / 100
HOLD
Tech 61.0
Fund 62.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TPST -96.14%
FEMY +54.78%
Spread: +150.92 pp (FEMY Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TPST Revenue | FEMY Revenue | TPST Op. Margin | FEMY Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2016 | $0M | N/A | -12406.1% | N/A | TPST |
| FY2017 | $0M | N/A | -28585.1% | N/A | TPST |
| FY2020 | N/A | $0M | N/A | -668.0% | FEMY |
| FY2021 | N/A | $0M | N/A | -706.7% | FEMY |
| FY2022 | N/A | $0M | N/A | -961.7% | FEMY |
| FY2023 | N/A | $0M | N/A | -1353.4% | FEMY |
| FY2024 | N/A | $0M | N/A | -1091.8% | FEMY |
| FY2025 | N/A | $0M | N/A | -767.0% | FEMY |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TPST | FEMY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.6M | $11.9M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -18.9% | Higher Growth | TPST |
| Operating Margin (TTM) Profitability | 0.0% | -763.9% | Higher Margin | TPST |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -1797.6% | -425.0% | Higher ROE | FEMY |
| 52-Week Range Position Momentum | 0% ($0โ$10) | 17% ($0โ$6) | Stronger Trend | FEMY |
| Beta / 30D Volatility Risk Regime | 0.75ฮฒ ยท 89% Vol | 4.01ฮฒ ยท 72% Vol | Lower Realized Risk | FEMY |
| Unified Institutional Score Composite Signal | 39.3 / 100 (SELL) | 52.6 / 100 (HOLD) | Higher Composite | FEMY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TPST vs FEMY Buy Guide
TPST
BREAKDOWN
40d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
FEMY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TPST nor FEMY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.